Medical product classification varies across Latin America, with a focus on how regulatory differences impact market access and the importance of local expertise in navigating these complexities.

Pharmaceutical companies are advancing supply chain sustainability, with a focus on reducing carbon emissions, improving logistics efficiency, and adopting more environmentally responsible practices.

In partnership with RARE Revolution, Tanner Pharma Group co-hosted a webinar bringing together stakeholders to discuss early access pathways, including collaboration, communication, real-world data, and patient access.